These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 17696842)

  • 1. Increased uptake of technetium-99m HDP in the subcortical area of both femurs in a patient with Graves' disease.
    Bisschop PH; Adam JA; Wiersinga WM
    Thyroid; 2007 Jul; 17(7):689-90. PubMed ID: 17696842
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased bone alkaline phosphatase and isolated subcortical bone uptake of technetium-99m hydroxymethylene diphosphonate in the lower extremities in a patient with Graves' disease: a distinctly unusual variant of Graves' acropachy.
    Ogrin C
    Thyroid; 2008 Nov; 18(11):1227-9. PubMed ID: 19014329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves' disease.
    Burggasser G; Hurtl I; Hauff W; Lukas J; Greifeneder M; Heydari B; Thaler A; Wedrich A; Virgolini I
    J Nucl Med; 2003 Oct; 44(10):1547-55. PubMed ID: 14530465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of Tc-99m pertechnetate by lactating breasts during a thyroid scan in a postpartum patient.
    Chew CG; Sotiropoulos P
    Clin Nucl Med; 2003 May; 28(5):441-2. PubMed ID: 12702955
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatostatin receptor scintigraphy using (99m)Tc-EDDA/HYNIC-TOC in graves' disease.
    Gabriel M; Decristoforo C; Moncayo R
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1267. PubMed ID: 12418470
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyroid blood flow and uptake of technetium-99m pertechnetate in Graves' disease.
    Sekulić V; Rajić M; Vlajković M; Ilić S; Bogićević M; Antić S; Dimić D
    Hell J Nucl Med; 2006; 9(3):173-6. PubMed ID: 17160158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging somatostatin receptor activity in patients with active thyroid eye disease using Tc-99m depreotide.
    Doumas AS; Krassas GE; Kaltsas T; Pontikides N
    Clin Nucl Med; 2003 May; 28(5):439-40. PubMed ID: 12702954
    [No Abstract]   [Full Text] [Related]  

  • 8. Active retrobulbar inflammation in Graves' ophthalmopathy visualized by Tc-99m DTPA SPECT.
    Galuska L; Varga J; Szucs Farkas Z; Garai I; Boda J; Szabo J; Leovey A; Nagy EV
    Clin Nucl Med; 2003 Jun; 28(6):515-6. PubMed ID: 12917542
    [No Abstract]   [Full Text] [Related]  

  • 9. Two unusual cases of Graves' hyperthyroidism with unilaterally increased 99mTc uptake.
    Decallonne B; Vanderstappen H; Thijs M
    Acta Clin Belg; 2012; 67(4):306-7. PubMed ID: 23019811
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased F-18 fluorodeoxyglucose thyroidal uptake in Graves' disease.
    Santiago JF; Jana S; El-Zeftawy H; Naddaf S; Abdel-Dayem HM
    Clin Nucl Med; 1999 Sep; 24(9):714-5. PubMed ID: 10478760
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed tc-99m sestamibi washout in graves' disease.
    Balan KK; Baltrop AH; Wishart GC
    Clin Nucl Med; 2003 Mar; 28(3):239-40. PubMed ID: 12592140
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased Tc-99m DTPA uptake in active Graves' ophthalmopathy and pretibial myxoedema.
    Alevizaki-Harhalaki M; Alevizaki C; Georgiou E; Proukauis C; Ikkos D
    J Nucl Med; 1983 Feb; 24(2):174-6. PubMed ID: 6337239
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thyroid gland hemiagenesis with Graves' disease].
    Mikosch P; Gallowitsch HJ; Kresnik E; Lind P
    Nuklearmedizin; 1999; 38(1):35-7. PubMed ID: 9987780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aseptic necrosis of the knee: bone scintigraphy.
    Burt RW; Matthews TJ
    AJR Am J Roentgenol; 1982 Mar; 138(3):571-3. PubMed ID: 6461229
    [No Abstract]   [Full Text] [Related]  

  • 15. Scintigraphic findings of the thyroid in euthyroid ophthalmic Graves' disease.
    Kasagi K; Hidaka A; Misaki T; Miyamoto S; Takeuchi R; Sakahara H; Sasayama S; Iida Y; Konishi J
    J Nucl Med; 1994 May; 35(5):811-7. PubMed ID: 8176463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative biological effectiveness of 99mTc radiopharmaceuticals.
    Narra VR; Sastry KS; Goddu SM; Howell RW; Strand SE; Rao DV
    Med Phys; 1994 Dec; 21(12):1921-6. PubMed ID: 7700199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant thyrotropin-induced orbital uptake of [111In-diethylenetriamine-pentacetic acid-D-Phe1]octreotide in a patient with inactive Graves' ophthalmopathy.
    Savastano S; Pivonello R; Acampa W; Salvatore M; Lombardi G; Colao A; Fenzi G
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2440-4. PubMed ID: 15687327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of radionuclide imaging in hyperthyroid patients with no clinical suspicion of nodules.
    Lacey NA; Jones A; Clarke SE
    Br J Radiol; 2001 Jun; 74(882):486-9. PubMed ID: 11459726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Simultaneous occurrence of Graves' ophthalmopathy and autonomous thyroid nodules].
    Smolarz K; Dederichs B; Schicha H
    Nuklearmedizin; 1998; 37(6):213-7. PubMed ID: 9770716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hemiagenesis associated with Graves' disease and Graves' ophthalmopathy: case report.
    Ozgen AG; Saygili F; Kabalak T
    Thyroid; 2004 Jan; 14(1):75-7. PubMed ID: 15009918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.